Abstract
BackgroundInfluenza in infancy can cause significant morbidity and mortality. This study aimed to characterize influenza outcomes in infants < ορ = 12 months and identify risk factors for severe infection.MethodsA retrospective cohort of infants ≤ 12 months born between 2011-2019 who received longitudinal ambulatory and inpatient care within a multi-facility hospital system and had laboratory-confirmed influenza were included. Perinatal, medical and illness characteristics were described. Risk factors for severe influenza (hospitalization, intensive-care unit (ICU) admission, secondary bacterial infections) were analyzed using Chi-square analysis and multivariate logistic regression.ResultsAmong 421 infants with influenza, 134 (32%) were < 6 months (m), 28 (6.5%) were born prematurely (< 35 weeks gestational age), and 41(10%) had chronic medical conditions (CMC). 62 (15%) required hospital admission, 13 (21%) of which required ICU care. No deaths were reported. Secondary bacterial infections were diagnosed in 101 (24%) including acute otitis media (84%), pneumonia (15%) and sinusitis (3%). Prematurity (OR 3.6, 95%CI:1.5-8.3), age < 6m (OR 3.4, 95%CI:1.9-5.9), and CMC (OR 7.6, 95%CI 3.8-15.3) were significantly associated with hospitalization. Prematurity, age < 6m, and CMC were also associated with ICU admission. Infants > 6m (OR 2, 95%CI:1.2-3.5) were more likely to be diagnosed with a secondary bacterial infection than younger infants. Among infants > 6m, complete influenza vaccination (2 doses) was associated with lower rates of antibiotic use (OR 0.5, 95% CI:0.3-0.9) compared to partial or no vaccination, but did not significantly affect hospitalization, ICU admission, or frequency of secondary bacterial infections. Adjusting for prematurity, age < 6m remained associated with hospitalization (aOR 4, 95%CI: 2.1-7.3) as did presence of CMC (aOR 7.3, 95%CI 3.3- 15.7). For ICU admission, age < 6m (aOR 6.3, 95%CI:1.6-24.1) and CMC (aOR 19.7,95%CI:4.9-79.5) were also independent risk factors. ConclusionYounger age and chronic medical conditions were independent risk factors for severe influenza infection. Complete influenza vaccination in eligible age groups was associated with decreased antibiotic use. Disclosures John V. Williams, MD, GlaxoSmithKline (Advisor or Review Panel member, Independent Data Monitoring Committee)Quidel (Advisor or Review Panel member, Scientific Advisory Board) Judith M. Martin, MD, Merck Sharp and Dohme (Consultant)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.